Amal Aziz

A Switchable, Dual-Functioning Trojan Horse for Alzheimer’s Disease Photothera

Sir Wilfrid Laurier S.S.

Blood-brain barrier drug delivery problems of existing neuropharmaceuticals can be solved using genetically engineered molecular Trojan horses. A novel tailor-made Trojan horse drug that quickly switches into an aggressive molecule to destroy even the residual amyloid plaques could be more effective than any known drug thus far developed for Alzheimer’s disease.

Awards
Youth Can Innovate Awards – Senior. Sponsor: The Gwyn Morgan and Patricia Trottier Foundation
Excellence Award – Senior Gold Medal
Western University  – $4000 Entrance Scholarship
Carleton University – $4000 Entrance Scholarship
Dalhousie University Faculty of Science  – $5000 Entrance Scholarship
UBC Science (Vancouver)  – $4000 Entrance Scholarship
University of Manitoba  – $5000 Entrance Scholarship
University of Ottawa – $4000 Entrance Scholarship

 

Biography

Amal is enrolled in the enrichment program at Sir Wilfrid Laurier S.S. She enjoys reading, graphic designing, and playing the viola and piano. Amal has won a few honors/awards from the Gauss Contest, the Canadian Royal Legion Speech Contest, the Thames Valley Science and Engineering Fair, the Canada Wide Science Fair, and the Sanofi Biogenius Competition. In her project, Amal proposes that the blood-brain barrier drug delivery problems of existing neuropharmaceuticals can be solved using genetically engineered molecular Trojan horses. A novel, tailor-made, photoactive, Trojan horse drug that quickly switches into an aggressive molecule to destroy even residual amyloid plaques could be more effective than any other known drug developed for Alzheimer’s disease thus far.